Comparison of the opioid receptor antagonist properties of naltrexone and 6β-naltrexol in morphine-naïve and morphine-dependent mice

European Journal of Pharmacology

Volumn 583, Issue 1, 2008, Pages 48-55

  Divin, Mary F ^a   Holden Ko, M C ^a   Traynor, John R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

(Mouse); 6 naltrexol; Dependence; Morphine; Naltrexone; Withdrawal

Indexed keywords

17 METHYL 3 HYDROXYPYRROLIDINO 2' PHENYL 7ALPHA METHYL 6,14 ETHENO MORPHINAN; BU 72; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALTREXOL; NALTREXONE; OPIATE ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG INHIBITION; DRUG POTENCY; HOT PLATE TEST; IN VIVO STUDY; JUMPING; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SWISS WEBSTER MOUSE; WITHDRAWAL SYNDROME;

ANIMALS; BINDING, COMPETITIVE; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED ICR; MORPHINANS; MORPHINE; MORPHINE DEPENDENCE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PAIN MEASUREMENT; PYRROLES; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 39649112849     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.01.004     Document Type: Article

References (25)

1. Aceto M.D. Characterization of prototypical opioid antagonists, agonist-antagonists, and agonists in the morphine-dependent rhesus monkey. Neuropeptides 5 (1984) 15-18
2. Arunlakshana O., and Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14 (1959) 48-58
3. Blasig J., Herz A., Reinhold K., and Zieglgansberger S. Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia (Berl) 33 (1973) 19-38
4. Blumberg H., and Ikeda C. Comparison of naltrexone and 6β-naltrexol in rats and mice. Fed. Proc. 35 (1976) 469
5. Bullingham R.E., McQuay H.J., and Moore R.A. Clinical pharmacokinetics of narcotic agonist-antagonist drugs. Clin. Pharmacokinet. 8 (1983) 332-343
6. Chatterjie N., Inturrisi C.E., Dayton H.B., and Blumberg H. Stereospecific synthesis of the 6β-hydroxy metabolites of naltrexone and naloxone. J. Med. Chem. 18 (1975) 490-492
7. Ferrari A., Bertolotti M., Dell'Utri A., Avico U., and Sternieri E. Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addicts. Drug Alcohol Depend. 52 (1998) 211-220
8. Fujimoto J.M., Roerig S., Wang R.I.H., Chatterjie N., and Inturrisi C.E. Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine dependent mice. Proc. Soc. Exp. Biol. Med. 148 (1975) 443-448
9. Garner H.R., Burke T.F., Lawhorn C.D., Stoner J.M., and Wessinger W.D. Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement. J. Pharmacol. Exp. Ther. 282 (1997) 1253-1261
10. 2 analysis in rhesus monkeys. J. Pharmacol. Exp. Ther. 285 (1998) 518-526
11. Ko M.C., Divin M.F., Lee H., Woods J.H., and Traynor J.R. Differential in vivo potencies of naltrexone and 6β-naltrexol in the monkey. J. Pharmacol. Exp. Ther. 316 (2006) 772-779
12. Maldonado R., Mico J.A., Valverde O., Saavedra M.C., Leonsegui I., and Gibert-Rahola J. Influence of different benzodiazepines on the experimental morphine abstinence syndrome. Psychopharmacology (Berl) 105 (1991) 197-203
13. Malspeis L., Bathala M.S., Ludden T.M., Bhat H.B., Frank S.G., Sokoloski T.D., Morrison B., and Reuning R.H. Metabolic reduction of naltrexone.1. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol or beta-naltrexol. Res. Commum. Chem. Path. Pharmacol. 12 (1975) 43-65
14. Nelson T.D., Davis R.D., and Nelson W.L. Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6α- and 6β-naltrexol. J. Med. Chem. 37 (1994) 4270-4277
15. Neilan C.L., Husbands S.M., Breeden S., Ko M.C., Aceto M.D., Lewis J.W., Woods J.H., and Traynor J.R. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist. Eur. J. Pharmacol. 499 (2004) 107-116
16. Porter S.J., Somogyi A.A., and White J.M. In vivo and in vitro potency studies of 6β-naltrexol, the major human metabolite of naltrexone. Addict. Biol. 7 (2002) 219-225
17. Raehal K.M., Lowery J.J., Bhamidipati C.M., Paoline R.M., Blair J.R., Wang D., Sadee W., and Bilsky E.J. In vivo characterization of 6β-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice. J. Pharmacol. Exp. Ther. 313 (2005) 1150-1162
18. Sadee W., Wang D., and Bilsky E.J. Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities. Life Sci. 76 (2005) 1427-1437
19. Valentino R.J., Katz J.L., Medzihradsky F., and Woods J.H. Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists. Life Sci. 32 (1983) 2887-2896
20. Van Wimersma Greidanus T.J., Donker D.K., Walhof R., Van Grafhorst J.C., De Vries N., Van Schaik S.J., Maigret C., Spruijt B.M., and Colbern D.L. The effects of neurotensin, naloxone and haloperidol on elements of excessive grooming behavior induced by bombesin. Peptides 6 (1985) 1179-1183
21. Walker E.A., and Sterious S.N. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence. Br. J. Pharmacol. 145 (2005) 975-983
22. Wang Z., Bilsky E.J., Porreca F., and Sadee W. Constitutive mu-opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci. 54 (1994) PL339-PL350
23. Wang D., Raehal K.M., Bilsky E.J., and Sadee W. Inverse agonists and neutral antagonists at μ opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. J. Neurochem. 77 (2001) 1590-1600
24. Wang D., Raehal K.M., Lin E.T., Lowery J.J., Kieffer B.L., Bilsky E.J., and Sadee W. Basal signaling activity of μ opioid receptor in mouse brain: role in narcotic dependence. J. Pharmacol. Exp. Ther. 308 (2004) 512-520
25. Woods J.H., and Gmerek D.E. Substitution and primary dependence studies in animals. Drug Alcohol Depend. 14 (1985) 233-247